Arbutus Biopharma (ABUS) Interest Expenses (2017 - 2026)
Arbutus Biopharma's Interest Expenses was $18,000 in Q2 2026, down 35.7% from $28,000 a year earlier but up 5.9% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Interest Expenses (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arbutus Biopharma's Interest Expenses was $76,000 through Jun 30, 2026, down 33.9% year-over-year; for FY2025, it came in at $97,000, down 29.2% from FY2024.
- Interest Expenses has now declined for five consecutive years, with a five-year compound annual growth rate of -52.5% (FY2020 to FY2025).
- In earlier years, Interest Expenses was $137,000 in FY2024 (-70.2%), $459,000 in FY2023 (-73.4%), $1.73 million in FY2022 (-39.6%) and $2.86 million in FY2021 (-28.8%).
- Quarterly Interest Expenses has moved between $17,000 (Q1 2026) and $762,000 (Q3 2021) over five years.
- Compared with a year earlier, Interest Expenses has declined for 24 straight quarters, with an average decline of 32.3% over the last eight quarters.
- The year-over-year decline in Interest Expenses has ranged between 17.6% (Q2 2025) and 89.3% (Q3 2023) over the last five years.
- Per Business Quant data, ABUS's Interest Expenses in the three quarters before Q2 2026 was $17,000 (Q1 2026), $18,000 (Q4 2025) and $23,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Arbutus Biopharma | 755.33 Mn | 382.30 Mn | - | 18,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 34,000.00 |
| Mar 31, 2024 | 44,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Jun 30, 2023 | 171,000.00 |
| Mar 31, 2023 | 198,000.00 |
| Dec 31, 2022 | 309,000.00 |
| Sep 30, 2022 | 429,000.00 |
| Jun 30, 2022 | 482,000.00 |
| Mar 31, 2022 | 506,000.00 |
| Dec 31, 2021 | 560,000.00 |
| Sep 30, 2021 | 762,000.00 |
API Access
Arbutus Biopharma Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();